BiomeSense is developing an integrated biosensor & cloud-based software platform to massively scale the collection and analysis of gut microbiome data, producing up to 30x the data of existing tools for the same or lower cost. The enabling technology is a proprietary microfluidic biosensor that's installed in the patient home, passively and continuously sampling the gut microbiome without any input from the patient.
The company's first market is clinical research, exponentially increasing the data available during clinical trials. After this market, the company plans to rapidly move to clinical use as a companion / traditional diagnostic, and long-term, the ultimate vision is to become a widespread consumer product to enable everyone to track and understand their microbiome for better health.
BiomeSense NewsVIEW ALL
You might also be interested in
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.